Zobrazeno 1 - 10
of 323
pro vyhledávání: '"A. W. Blayney"'
Autor:
Douglas W. Blayney, Giovanni Bariani, Devika Das, Shaheenah Dawood, Michael Gnant, Roselle De Guzman, S. Eric Martin, Deirdre O'Mahony, Alex Roach, Paul Ruff, Carlos Sampaio, Jose Angel Sanchez, Verna Vanderpuye, Arif Kamal, Carolyn Hendricks
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1513-1521 (2021)
This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares
Externí odkaz:
https://doaj.org/article/7e3236c344e14ced80a2bd177ed1dce3
Autor:
Amee D. Azad, Melih Yilmaz, Selen Bozkurt, James D. Brooks, Douglas W. Blayney, Tina Hernandez‐Boussard
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 5783-5793 (2021)
Abstract Background High‐value cancer care balances effective treatment with preservation of quality of life. Chemotherapy is known to affect patients’ physical and psychological well‐being negatively. Patient‐reported outcomes (PROs) provide
Externí odkaz:
https://doaj.org/article/97ccd48d51a843c58e817b8363e15d8b
Publikováno v:
Trauma Surgery & Acute Care Open, Vol 7, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/ad99c676895e47daa9f9cd5ccc602837
Autor:
Elizabeth Sainsbury, Ronaldo do Amaral, Alexander W. Blayney, Rory McConn Walsh, Fergal J. O'Brien, Cian O'Leary
Publikováno v:
Biomaterials and Biosystems, Vol 6, Iss , Pp 100046- (2022)
Despite the high success rate of autologous grafts in tympanic membrane repair, clinical alternatives are required for the closure of unresponsive chronic perforations that can lead to recurring infection and hearing loss. Tissue engineering and rege
Externí odkaz:
https://doaj.org/article/7ad9e81b2702444bac21e692c196e5c9
Autor:
Christopher J. Magnani, Nicolas Bievre, Laurence C. Baker, James D. Brooks, Douglas W. Blayney, Tina Hernandez-Boussard
Publikováno v:
European Urology Open Science, Vol 23, Iss , Pp 20-29 (2021)
Background: Prostate cancer is the most common cancer in men and second leading cause of cancer-related deaths. Changes in screening guidelines, adoption of active surveillance (AS), and implementation of high-cost technologies have changed treatment
Externí odkaz:
https://doaj.org/article/49e0fc0c750e48f6b0516acb45f26012
Autor:
Douglas W. Blayney, Nafisa Albdelhafeez, Abdul Rahman Jazieh, Carlos Frederico Pinto, Adrian Udrea, Alex Roach, Devika Das, Stephen Grubbs, John Hamm, Mohammad Jahanzeb, Arif H. Kamal, Ronan J. Kelly, S. Eric Martin, Deirdre O'Mahony, Walter Birch, Ronda Bowman, Stéphanie T. S. Crist, Amy Evers, Terry Gilmore, Meredith Klein, Robert Siegel
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 697-703 (2020)
Externí odkaz:
https://doaj.org/article/689d6c41e9d641f3a470e74d824019e4
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8552-8561 (2020)
Abstract Purpose Prior studies suggest email communication between patients and providers may improve patient engagement and health outcomes. The purpose of this study was to determine whether patient‐initiated emails are associated with overall su
Externí odkaz:
https://doaj.org/article/991c5d001620466e88e379bd41235d03
Autor:
Helena S. Francis, Caroline L. Harold, Robert A. Beagrie, Andrew J. King, Matthew E. Gosden, Joseph W. Blayney, Danuta M. Jeziorska, Christian Babbs, Douglas R. Higgs, Mira T. Kassouf
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Mouse embryonic stem cells (mESCs) can be manipulated in vitro to recapitulate the process of erythropoiesis, during which multipotent cells undergo lineage specification, differentiation and maturation to produce erythroid cells. Although useful for
Externí odkaz:
https://doaj.org/article/baa5ea583f194f4d8f3af8a8cc7078c9
Publikováno v:
Cancer Investigation. 41:369-378
Autor:
Long H. Dang, Nam H. Dang, Brad St. Croix, William D. Ensminger, Douglas W. Blayney, Marcia Cruz-Correa, Nicholas J. Vogelzang, Elisabeth I. Heath, Nicola J. Mabjeesh, Pamela Havre, Shaowei Chen, Masako Abe, Kyunghee Burkitt, Sang Y. Chun, Duyen T. Dang
Antiangiogenic therapy improves survival in patients with advanced stage cancers. Currently, there are no reliable predictors or markers for tumor vessel response to antiangiogenic therapy. To model effective antiangiogenic therapy, we disrupted the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c393b5a382d5d6c9d2c316bb4dfc7a4c
https://doi.org/10.1158/0008-5472.c.6497498
https://doi.org/10.1158/0008-5472.c.6497498